North America Aptamers Market By Type, By Application, By Technology, By End User, By Country, Opportunity Analysis and Industry Forecast, 2021-2027

The North America Aptamers Market is expected to witness market growth of 17.4% CAGR during the forecast period (2021-2027).

Aptamers have been investigated as a bio-material in a variety of studies involving its usage as a diagnostic and therapeutic tool, as well as a bio-sensing probe, and in the creation of new medications, drug delivery systems, and other applications. Attempts have been made to find aptamers that are specific to targets involved in diseases like cancer and viral infection. Aptamers have mostly been researched for use as diagnostic or therapeutic tools.

Aptamers are oligonucleotides that bind to specific targets such as proteins, peptides, carbohydrates, tiny compounds, poisons, and living cells. In comparison to antibodies, they are changeable, non-immunogenic, highly sensitive, less poisonous, easy to create, and have a low molecular weight with no fluctuation across preparations. As a result, they're commonly used in biotechnological and medicinal applications.

Factors such as technological breakthroughs and increased R&D activity are expected to boost the demand for aptamers. Because of favorable government efforts and an increasing number of research laboratories, the United States is a market leader in North America. Due to quick technological breakthroughs and substantial investment and funding to assist the development of aptamers, the North American region dominates the industry.

The US market dominated the North America Aptamers Market by Country 2020, and is expected to continue to be a dominant market till 2027; thereby, achieving a market value of $123.6 million by 2027. The Canada market is anticipated to grow a CAGR of 20.1% during (2021 - 2027). Additionally, The Mexico market is expected to witness a CAGR of 19.1% during (2021 - 2027).

Based on Type, the market is segmented into DNA Aptamers, XNA Aptamers and RNA Aptamers. Based on Application, the market is segmented into Therapeutics Development, Research & Development, Diagnostic and Others. Based on Technology, the market is segmented into SELEX and Others. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic & Government Research Institutes, CROs and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Kaneka Corporation, Aptamer Group PLC, SomaLogic, Inc., RayBiotech Life, Inc., Neoventures Biotechnology, Inc., Maravai Lifesciences Holdings, Inc., Aptus Biotech, Base Pair Biotechnologies, Inc., Alpha Diagnostic International, Inc., and Vivonics, Inc.

Scope of the Study

Market Segments Covered in the Report:

By Type

• DNA Aptamers
• XNA Aptamers and
• RNA Aptamers

By Application

• Therapeutics Development
• Research & Development
• Diagnostic and
• Others

By Technology

• SELEX and
• Others

By End User

• Pharmaceutical & Biotechnology Companies
• Academic & Government Research Institutes
• CROs and
• Others

By Country

• US
• Canada
• Mexico
• Rest of North America

Key Market Players

List of Companies Profiled in the Report:

• Kaneka Corporation
• Aptamer Group PLC
• SomaLogic, Inc.
• RayBiotech Life, Inc.
• Neoventures Biotechnology, Inc.
• Maravai Lifesciences Holdings, Inc.
• Aptus Biotech
• Base Pair Biotechnologies, Inc.
• Alpha Diagnostic International, Inc.
• Vivonics, Inc.

Unique Offerings from the Publisher

• Exhaustive coverage
• The highest number of market tables and figures
• Subscription-based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free